Linked infacebooktwitteryoutube
inflammatory bowel disease

AbbVie and FutureGen Enter License Agreement for Advanced Inflammatory Bowel Disease Therapy


Roche's PD-L1 Assay Receives Expanded CE Mark as Companion Diagnostic for Libtayo in Combination with Chemotherapy


Indian TB Diagnostic Technology Receives Praise at World Health Assembly

Solid Tumors

FDA Grants Accelerated Approval to Augtyro™ (Repotrectinib) for NTRK-Positive Locally Advanced or Metastatic Solid Tumors

High-Throughput NGS

QIAGEN ‘s QCI Interpret Software Enhances Clinical Reporting Speed for High-Throughput NGS Testing Labs


Approval Granted: Applied DNA's TR8(TM) Pharmacogenomic (PGx) Testing Service Receives Green Light from New York State Department of Health


Sirnaomics Unveils Robust Antitumor Efficacy of Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy

Digital PCR

QIAGEN Introduces Advanced QIAcuity Digital PCR Assays for Microbial Studies, Elevating Infectious Disease Research and Surveillance


DRAGEN v4.3 by Illumina: Advancing the Most Comprehensive and Accurate Genome with Cutting-Edge Innovations


Transforming Healthcare: The Rise of Genomic Urine Testing

HRD Testing

Myriad Genetics Partners with GSK to Enhance HRD Testing Accessibility Across Nine Nations

Precision Medicine

Unveiling the Future of Cancer Care: Join Diaceutics' Virtual Event on Precision Medicine in Oncology

Continuous Glucose Monitors

FDA Clears Abbott's Over-the-Counter Continuous Glucose Monitors


FDA Prioritizes AstraZeneca's Tagrisso sNDA for Priority Review in Unresectable Stage III NSCLC


Advancements in Biomarkers for Early Cancer Detection